Lv51
966 积分 2024-06-07 加入
Donanemab in Early Symptomatic Alzheimer Disease
9天前
已完结
Top advances of the year: Small cell lung cancer
26天前
已完结
P3.13D.11 SEZ6 Expression in Neuroendocrine Tumors
28天前
已完结
Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma
29天前
已完结
P3.13D.09 Prevalence and Prognostic Impact of SEZ6 Expression in a Real-World Cohort of Patients with Small-Cell Lung Cancer
1个月前
已完结
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
1个月前
已完结
Pilot-phase PET/CT study targeting integrin αvβ6 in pancreatic cancer patients using the cystine-knot peptide–based 18F-FP-R01-MG-F2
1个月前
已完结
Diagnostic efficacy of [68Ga]Ga-NY104 PET/CT to identify clear cell renal cell carcinoma
1个月前
已完结
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma
1个月前
已完结
Preclinical Characterization of DPI-4452: A68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IX
1个月前
已完结
皖公网安备34019202002308
